Baker, G. B., Sowa, B., & Todd, Kathryn G. (2007). Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? Journal of Psychiatry and Neuroscience, 32, 313–315. Bian, Q., Kato, T., Monji, A., Hashioka, S., Mizoguchi, Y., Horikawa, H., & Kanba, S. (in press). The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-a. Progress in Neuropsychopharmacology and Biological Psychiatry. Connor, B., & Dragunow, M. (1998). The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Research. Brain Research Reviews, 27, 1–39. Cui, J., Shao, L., Young, L. Trevor, & Wang, Jia Fu. (2007). Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144, 1447–1453. Jann, M. W. (2004). Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis. Pharmacotherapy 24, 1759–1783. Li, X.-M. & Xu, H. (2007). Evidence for neuroprotective effects of antipsychotic drugs: Implications for the pathophysiology and treatment of schizophrenia. International Review Neurobiology 77, 107–142. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., & Hen, R. (2003). Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 301, 805–809. Schiepers, O. J.G., Wichers, M. C., and Maes, M. (2005). Cytokines and depression. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 201–217. Schloesser, R. J., Chen, G., & Manji, H. (2007). Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder. International Review Neurobiology, 77, 143–178. Wood, P. L., Khan, M. A., Manji, J. R., Todd, K. G., Tanay, V. A.M.I., & Baker, G. B. (2006). Aldehyde load in ischemia-reperfusion brain injury: Neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Research, 1122, 184–190. Youdim, M. B.H., Edmondson, D., & Tipton, K. F. (2006). The therapeutic potential of monoamine oxidase inhibitors. Nature Reviews Neuroscience, 7, 295–309. Young, L. T. (2002). Neuroprotective effects of antidepressant and mood stabilizing drugs. Journal of Psychiatry and Neuroscience, 27, 8–9. Young, L. T. (2007). Is bipolar disorder a mitochondrial disease? Journal of Psychiatry and Neuroscience, 32, 160–161.